U.S. flag

An official website of the United States government

NM_001127649.3(PEX26):c.134T>C (p.Leu45Pro) AND Peroxisome biogenesis disorder 7A (Zellweger)

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 30, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000351940.7

Allele description [Variation Report for NM_001127649.3(PEX26):c.134T>C (p.Leu45Pro)]

NM_001127649.3(PEX26):c.134T>C (p.Leu45Pro)

Gene:
PEX26:peroxisomal biogenesis factor 26 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q11.21
Genomic location:
Preferred name:
NM_001127649.3(PEX26):c.134T>C (p.Leu45Pro)
HGVS:
  • NC_000022.11:g.18078510T>C
  • NG_008339.1:g.5591T>C
  • NM_001127649.3:c.134T>CMANE SELECT
  • NM_001199319.2:c.134T>C
  • NM_017929.6:c.134T>C
  • NP_001121121.1:p.Leu45Pro
  • NP_001186248.1:p.Leu45Pro
  • NP_060399.1:p.Leu45Pro
  • NC_000022.10:g.18561276T>C
  • NM_017929.5:c.134T>C
  • Q7Z412:p.Leu45Pro
Protein change:
L45P; LEU45PRO
Links:
UniProtKB: Q7Z412#VAR_018647; OMIM: 608666.0006; dbSNP: rs61752132
NCBI 1000 Genomes Browser:
rs61752132
Molecular consequence:
  • NM_001127649.3:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001199319.2:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_017929.6:c.134T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Peroxisome biogenesis disorder 7A (Zellweger)
Synonyms:
Peroxisome biogenesis disorder 7A
Identifiers:
MONDO: MONDO:0013938; MedGen: C3888385; Orphanet: 912; OMIM: 614872

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000437325Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Uncertain significance
(Apr 28, 2017)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV004201496Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 30, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

Matsumoto N, Tamura S, Furuki S, Miyata N, Moser A, Shimozawa N, Moser HW, Suzuki Y, Kondo N, Fujiki Y.

Am J Hum Genet. 2003 Aug;73(2):233-46. Epub 2003 Jul 8.

PubMed [citation]
PMID:
12851857
PMCID:
PMC1180364

Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis.

Weller S, Cajigas I, Morrell J, Obie C, Steel G, Gould SJ, Valle D.

Am J Hum Genet. 2005 Jun;76(6):987-1007. Epub 2005 Apr 27.

PubMed [citation]
PMID:
15858711
PMCID:
PMC1196456
See all PubMed Citations (5)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000437325.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The PEX26 c.134T>C (p.Leu45Pro) missense variant was reported in a compound heterozygous state with a second missense variant in one individual with infantile Refsum disease, which is part of the Zellweger spectrum (Matsumoto et al. 2003). Control data are not available and allele frequency information for this variant is not reported in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. Expression of the p.Leu45Pro variant in a PEX26-deficient CHO cell line showed that the variant did not restore impaired peroxisome biogenesis (Matsumoto et al. 2003, Weller et al. 2005) and interfered with interactions with other PEX proteins (Furuki et al. 2006; Tamura et al. 2014). Based on the evidence, the p.Leu45Pro variant is classified as a variant of unknown significance but suspicious for pathogenicity for Zellweger syndrome spectrum. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004201496.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024